Stock 300583 SHANDONG SITO BIO-TECHNOLOGY CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Financials Shandong Sito Bio-technology Co., Ltd.

Equities

300583

CNE100002F36

Pharmaceuticals

End-of-day quote Shenzhen S.E.
Other stock markets
 06:00:00 2024-05-07 pm EDT 		5-day change 1st Jan Change
17.14 CNY +5.41% Intraday chart for Shandong Sito Bio-technology Co., Ltd. +16.52% -13.35%
May. 08 Shandong Sito Bio-technology Gets European Suitability Certification for Rhinitis Nasal Spray MT
Apr. 28 Shandong Sito Bio-technology Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI

Valuation

Fiscal Period: December 2020 2021 2024 2025 2026
Capitalization 1 2,532 2,647 3,168 - -
Enterprise Value (EV) 1 2,532 2,647 3,168 3,168 3,168
P/E ratio -14 x 72.6 x 57.1 x 43.9 x 39 x
Yield - - 0.06% 0.12% 0.12%
Capitalization / Revenue - - 2.26 x 2.06 x 1.9 x
EV / Revenue - - 2.26 x 2.06 x 1.9 x
EV / EBITDA - - 11.6 x 10.1 x 9.16 x
EV / FCF - - - - -
FCF Yield - - - - -
Price to Book - - 1.64 x 1.58 x 1.52 x
Nbr of stocks (in thousands) 171,928 171,604 189,702 - -
Reference price 2 14.72 15.42 17.14 17.14 17.14
Announcement Date 4/19/21 4/25/22 - - -
1CNY in Million2CNY
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2020 2021 2024 2025 2026
Net sales 1 - - 1,404 1,538 1,669
EBITDA 1 - - 272 315 346
EBIT 1 - - 67 85 98
Operating Margin - - 4.77% 5.53% 5.87%
Earnings before Tax (EBT) 1 - - 66 84 97
Net income 1 -179.8 36.21 57 73 84
Net margin - - 4.06% 4.75% 5.03%
EPS 2 -1.050 0.2125 0.3000 0.3900 0.4400
Free Cash Flow - - - - -
FCF margin - - - - -
FCF Conversion (EBITDA) - - - - -
FCF Conversion (Net income) - - - - -
Dividend per Share 2 - - 0.0100 0.0200 0.0200
Announcement Date 4/19/21 4/25/22 - - -
1CNY in Million2CNY
Estimates

Balance Sheet Analysis

Fiscal Period: December 2020 2021 2024 2025 2026
Net Debt - - - - -
Net Cash position - - - - -
Leverage (Debt/EBITDA) - - - - -
Free Cash Flow - - - - -
ROE (net income / shareholders' equity) - - 2.89% 3.56% 3.94%
ROA (Net income/ Total Assets) - - 1.7% 2.11% 2.34%
Assets 1 - - 3,353 3,460 3,590
Book Value Per Share 2 - - 10.50 10.80 11.30
Cash Flow per Share 2 - - 3.400 1.430 1.590
Capex 1 - - 171 182 213
Capex / Sales - - 12.18% 11.83% 12.76%
Announcement Date 4/19/21 4/25/22 - - -
1CNY in Million2CNY
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
17.14
Average target price
-
Consensus

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

1st Jan change Capi.
SHANDONG SITO BIO-TECHNOLOGY CO., LTD. Stock Shandong Sito Bio-technology Co., Ltd.
-13.35% 450M
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+33.63% 698B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+26.51% 568B
JOHNSON & JOHNSON Stock Johnson & Johnson
-4.49% 358B
MERCK & CO., INC. Stock Merck & Co., Inc.
+18.88% 328B
ABBVIE INC. Stock AbbVie Inc.
+3.89% 283B
ASTRAZENECA PLC Stock AstraZeneca PLC
+16.23% 238B
NOVARTIS AG Stock Novartis AG
+6.68% 203B
ROCHE HOLDING AG Stock Roche Holding AG
-9.08% 198B
AMGEN INC. Stock Amgen Inc.
+6.89% 165B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. 300583 Stock
  4. Financials Shandong Sito Bio-technology Co., Ltd.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW